Status:
COMPLETED
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
Lead Sponsor:
University of Lausanne Hospitals
Conditions:
Secondary or Tertiary Peritonitis
Eligibility:
All Genders
18+ years
Brief Summary
Procalcitonin level used for determining length of antibiotic treatment in peritonitis and intra-abdominal infections. Hypothesis is that length of antibiotic use can be shortened by this method.
Detailed Description
Prospective randomized trial
Eligibility Criteria
Inclusion
- More than 18 yo
- Patient requiring surgery for peritonitis or intra-abdominal infection following: perforation, necrosis, previous operation...
- Mannheim Peritonitis score \> 14
- SIRS present
- Probability of survival \> 72h
- Informed consent by patient/relatives
Exclusion
- No SIRS
- Long date corticoid treatment
- Immunosuppression
- Thyroid medullary carcinoma
- Anaphylactic shock
- Acute hepatic deficiency
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT01155739
Start Date
June 1 2009
End Date
June 1 2014
Last Update
December 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Lausanne
Lausanne, Switzerland, 1011